Lv1
40 积分 2023-12-21 加入
Ustekinumab use in Crohn’s disease: a Canadian tertiary care centre experience
14天前
已完结
Subcutaneous ustekinumab for the treatment of anti-TNF resistant Crohn's disease—The McGill experience
14天前
已完结
Patients with Refractory Crohnʼs Disease Successfully Treated with Ustekinumab
14天前
已完结
Modern Advanced Therapies for Inflammatory Bowel Diseases: Practical Considerations and Positioning
2个月前
已关闭
Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial
2个月前
已完结
Adenocarcinoma in strictures of ulcerative colitis without antecedent dysplasia by colonoscopy
2个月前
已关闭
Efficacy and safety of endoscopic balloon dilation in inflammatory bowel disease: results of the large multicenter study of the ENEIDA registry
4个月前
已完结
Detection of Dysplasia or Cancer in 3.5% of Patients With Inflammatory Bowel Disease and Colonic Strictures
4个月前
已完结
PANTS extension study: how best to use anti-TNF drugs in Crohn's disease
5个月前
已完结
Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study
5个月前
已完结
皖公网安备34019202002308
